OneOncology’s $2 billion “for sale” sign is an important warning that the next 2 to 3 years will bring new, unpredictable shocks to the community oncology ecosystem as stakeholders grapple to assert control over the healthcare dollar.
Read MoreWelcome to the March 2023 edition of our Monthly Insight Series. This month we discuss how Humana terminated its employer group line of business and the implications.
Chris Van DenburgWe want to give you a look at some of the topics we’re planning to explore this year, as we enter yet another period of rapid change, upheaval, and uncertainty in 2023-2025.
Lee BlansettWelcome to the February 2023 edition of our Monthly Insight Series. This month we discuss how community oncology providers are engaging in value-based care.
Taylor Crutison, Lee Blansett, Nandini JhaJoin us live to hear experts go head-to-head on controversial GI cancer topics. Through a comprehensive review of the latest clinical advancements in gastrointestinal malignancies, robust audience engagement, and ample discussion, participants…
A multi-day, debate-driven conference focusing on the treatment of blood cancer. The unique agenda provides opportunities to hear both sides of a current or controversial topic, allowing attendees to form well-rounded opinions based on…
A multi-day overview of the latest advances and clinical decision points in the treatment of breast and gynecological cancers. This conference is an opportunity to fill in some gaps we see in the oncology CME education landscape.